Clinical Trials on Adult Patients With Chronic Primary ITP in India

Total 3 results

AstraZeneca

Completed

FAsenra Safety Trial in India (FAST)

In Adult Patients of Severe Asthma With Eosinophilic Phenotype in India

India
Institute of Liver and Biliary Sciences, India

Withdrawn

Safety and Efficacy of Sofosbuvir Based Antiviral Regimen for Treating Hepatitis C in Patients With Moderate to Advanced Chronic Kidney Disease and Patients Receiving Renal Replacement Therapy

CKD With Hepatitis C

India
AstraZeneca

Recruiting

Study to Investigate Efficacy, Safety, and Tolerability of Zibotentan/Dapagliflozin Compared to Dapagliflozin in Participants With Chronic Kidney Disease and High Proteinuria (ZENITH High Proteinuria)

Chronic Kidney Disease With High Proteinuria

United Kingdom, Argentina, Italy, United States, Poland, Germany, Spain, Denmark, Sweden, France, China, Taiwan, Thailand, Vietnam, Brazil, Malaysia, Mexico, Philippines, Israel, Norway, Korea, Republic of, Canada, Japan, Turkey, Australia and more

3

Subscribe